Pharmaceutical firm pivots to stablecoins, holds nearly 9% of SKY's supply

A pharmaceutical firm has shifted its focus to stablecoins, now holding nearly 9% of the total supply of SKY, a cryptocurrency. This strategic move aims to leverage the stability of stablecoins in its financial operations. The firm believes that integrating digital assets can enhance its liquidity and operational efficiency. The decision reflects a growing trend among traditional companies exploring blockchain technology and cryptocurrencies for financial innovation.

Read the full article: CoinDesk

Read more